Taylor SM - Search Results

1

Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis.

Pavlovski D, Thundyil J, Monk PN, Wetsel RA, Taylor SM, Woodruff TM. Pavlovski D, et al. Among authors: taylor sm. FASEB J. 2012 Sep;26(9):3680-90. doi: 10.1096/fj.11-202382. Epub 2012 May 31. FASEB J. 2012. PMID: 22651932

2

Role of complement in motor neuron disease: animal models and therapeutic potential of complement inhibitors.

Woodruff TM, Costantini KJ, Taylor SM, Noakes PG. Woodruff TM, et al. Among authors: taylor sm. Adv Exp Med Biol. 2008;632:143-58. Adv Exp Med Biol. 2008. PMID: 19025120 Review.

3

Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration.

Woodruff TM, Crane JW, Proctor LM, Buller KM, Shek AB, de Vos K, Pollitt S, Williams HM, Shiels IA, Monk PN, Taylor SM. Woodruff TM, et al. Among authors: taylor sm. FASEB J. 2006 Jul;20(9):1407-17. doi: 10.1096/fj.05-5814com. FASEB J. 2006. PMID: 16816116

4

The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis.

Woodruff TM, Costantini KJ, Crane JW, Atkin JD, Monk PN, Taylor SM, Noakes PG. Woodruff TM, et al. Among authors: taylor sm. J Immunol. 2008 Dec 15;181(12):8727-34. doi: 10.4049/jimmunol.181.12.8727. J Immunol. 2008. PMID: 19050293

5

Complement factors C3a and C5a have distinct hemodynamic effects in the rat.

Proctor LM, Moore TA, Monk PN, Sanderson SD, Taylor SM, Woodruff TM. Proctor LM, et al. Among authors: taylor sm. Int Immunopharmacol. 2009 Jun;9(6):800-6. doi: 10.1016/j.intimp.2009.03.002. Epub 2009 Mar 12. Int Immunopharmacol. 2009. PMID: 19285573

6

Complement component 5a (C5a).

Manthey HD, Woodruff TM, Taylor SM, Monk PN. Manthey HD, et al. Among authors: taylor sm. Int J Biochem Cell Biol. 2009 Nov;41(11):2114-7. doi: 10.1016/j.biocel.2009.04.005. Epub 2009 Apr 11. Int J Biochem Cell Biol. 2009. PMID: 19464229 Review.

7

The role of the complement system and the activation fragment C5a in the central nervous system.

Woodruff TM, Ager RR, Tenner AJ, Noakes PG, Taylor SM. Woodruff TM, et al. Among authors: taylor sm. Neuromolecular Med. 2010 Jun;12(2):179-92. doi: 10.1007/s12017-009-8085-y. Epub 2009 Sep 11. Neuromolecular Med. 2010. PMID: 19763906

8

Complement C5a inhibition reduces atherosclerosis in ApoE-/- mice.

Manthey HD, Thomas AC, Shiels IA, Zernecke A, Woodruff TM, Rolfe B, Taylor SM. Manthey HD, et al. Among authors: taylor sm. FASEB J. 2011 Jul;25(7):2447-55. doi: 10.1096/fj.10-174284. Epub 2011 Apr 13. FASEB J. 2011. PMID: 21490292

9

C5L2: a controversial receptor of complement anaphylatoxin, C5a.

Li R, Coulthard LG, Wu MC, Taylor SM, Woodruff TM. Li R, et al. Among authors: taylor sm. FASEB J. 2013 Mar;27(3):855-64. doi: 10.1096/fj.12-220509. Epub 2012 Dec 13. FASEB J. 2013. PMID: 23239822 Review.

10

The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization.

Wu MC, Brennan FH, Lynch JP, Mantovani S, Phipps S, Wetsel RA, Ruitenberg MJ, Taylor SM, Woodruff TM. Wu MC, et al. Among authors: taylor sm. Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9439-44. doi: 10.1073/pnas.1218815110. Epub 2013 May 21. Proc Natl Acad Sci U S A. 2013. PMID: 23696668 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

863 results

Search Page

Filters